Advanced Approaches of the Use of CircRNAs As a Replacement for Cancer Therapy

Overview

Journal Noncoding RNA Res

Date 2024 Apr 9

PMID 38590433

Authors

Goran Sedeeq Hama Faraj

Bashdar Mahmud Hussen

Snur Rasool Abdullah

Mohammed Fatih Rasul

Yasaman Hajiesmaeili

Aria Baniahmad

Mohammad Taheri

Affiliations

Soon will be listed here.

Abstract

Cancer is a broad name for a group of diseases in which abnormal cells grow out of control and are characterized by their complexity and recurrence. Although there has been progress in cancer therapy with the entry of precision medicine and immunotherapy, cancer incidence rates have increased globally. Non-coding RNAs in the form of circular RNAs (circRNAs) play crucial roles in the pathogenesis, clinical diagnosis, and therapy of different diseases, including cancer. According to recent studies, circRNAs appear to serve as accurate indicators and therapeutic targets for cancer treatment. However, circRNAs are promising candidates for cutting-edge cancer therapy because of their distinctive circular structure, stability, and wide range of capabilities; many challenges persist that decrease the applications of circRNA-based cancer therapeutics. Here, we explore the roles of circRNAs as a replacement for cancer therapy, highlight the main challenges facing circRNA-based cancer therapies, and discuss the key strategies to overcome these challenges to improve advanced innovative therapies based on circRNAs with long-term health effects.

Citing Articles

Circular RNAs in cancer.

Guo Y, Huang Q, Heng Y, Zhou Y, Chen H, Xu C MedComm (2020). 2025; 6(2):e70079.

PMID: 39901896 PMC: 11788016. DOI: 10.1002/mco2.70079.

mRNA vaccines as cancer therapies.

Huang S, Que H, Wang M, Wei X Chin Med J (Engl). 2024; 137(24):2979-2995.

PMID: 39668413 PMC: 11706586. DOI: 10.1097/CM9.0000000000003455.

The role of circRNAs in resistance to doxorubicin.

Sanati M, Ghafouri-Fard S Cell Commun Signal. 2024; 22(1):572.

PMID: 39614315 PMC: 11607985. DOI: 10.1186/s12964-024-01952-9.

Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.

Racca L, Liuzzi E, Comparato S, Giordano G, Pignochino Y Int J Mol Sci. 2024; 25(16).

PMID: 39201617 PMC: 11354327. DOI: 10.3390/ijms25168934.

References

Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H . Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2018; 51(5):2324-2340. DOI: 10.1159/000495876. View

Liu J, Zhang X, Yan M, Li H . Emerging Role of Circular RNAs in Cancer. Front Oncol. 2020; 10:663. PMC: 7326090. DOI: 10.3389/fonc.2020.00663. View

Itoo A, Vemula S, Gupta M, Giram M, Kumar S, Ghosh B . Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release. 2022; 350:26-59. DOI: 10.1016/j.jconrel.2022.08.011. View

Shen Z, Zhou L, Zhang C, Xu J . Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2019; 468:88-101. DOI: 10.1016/j.canlet.2019.10.006. View

Luo Z, Rong Z, Zhang J, Zhu Z, Yu Z, Li T . Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol Cancer. 2020; 19(1):86. PMC: 7210689. DOI: 10.1186/s12943-020-01203-8. View

Ma X, Zhao Y, Liang X . Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res. 2011; 44(10):1114-22. DOI: 10.1021/ar2000056. View

Li F, Yang Q, He A, Yang B . Circular RNAs in cancer: Limitations in functional studies and diagnostic potential. Semin Cancer Biol. 2020; 75:49-61. DOI: 10.1016/j.semcancer.2020.10.002. View

Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T . CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018; 9(4):417. PMC: 5856798. DOI: 10.1038/s41419-018-0454-8. View

10.

Shen H, An O, Ren X, Song Y, Tang S, Ke X . ADARs act as potent regulators of circular transcriptome in cancer. Nat Commun. 2022; 13(1):1508. PMC: 8938519. DOI: 10.1038/s41467-022-29138-2. View

11.

Luo S, Deng F, Yao N, Zheng F . Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1. Anticancer Drugs. 2021; 33(1):e286-e298. DOI: 10.1097/CAD.0000000000001205. View

12.

Wang Q, Sun Y, Zhao Q, Wu W, Wang L, Miao Y . Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism. Animal Model Exp Med. 2022; 5(1):38-47. PMC: 8879624. DOI: 10.1002/ame2.12208. View

13.

Ji W, Qiu C, Wang M, Mao N, Wu S, Dai Y . Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. Biochem Biophys Res Commun. 2018; 497(1):122-126. DOI: 10.1016/j.bbrc.2018.02.036. View

14.

Wang Y, Li Y, He H, Wang F . Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498. Gene. 2019; 720:144099. DOI: 10.1016/j.gene.2019.144099. View

15.

Li H, Ma X, Li H . Intriguing circles: Conflicts and controversies in circular RNA research. Wiley Interdiscip Rev RNA. 2019; 10(5):e1538. DOI: 10.1002/wrna.1538. View

16.

Pei X, Chen S, Long X, Zhu S, Qiu B, Lin K . circMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis. Aging (Albany NY). 2020; 12(13):13038-13058. PMC: 7377868. DOI: 10.18632/aging.103392. View

17.

Zhong C, Long Z, Yang T, Wang S, Zhong W, Hu F . M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy. Int J Biol Sci. 2023; 19(5):1543-1563. PMC: 10086746. DOI: 10.7150/ijbs.77133. View

18.

Aung T, Qu Z, Kortschak R, Adelson D . Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int J Mol Sci. 2017; 18(3). PMC: 5372668. DOI: 10.3390/ijms18030656. View

19.

Wang L, Ma H, Kong W, Liu B, Zhang X . Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2. Biosci Rep. 2019; 39(6). PMC: 6549085. DOI: 10.1042/BSR20182433. View

20.

Meng L, Liu S, Liu F, Sang M, Ju Y, Fan X . ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway. Mol Ther Nucleic Acids. 2020; 22:124-137. PMC: 7490471. DOI: 10.1016/j.omtn.2020.08.015. View